Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat ...
Inc., a company specializing in laboratory analytical instruments, has terminated a material definitive agreement with Cowen and Company, LLC. This termination, effective February 14, 2025, was ...
KINSTON, NC and LAS VEGAS, NV, Feb. 14, 2025 (GLOBE NEWSWIRE) -- flyExclusive Inc. (NYSE American: FLYX), a publicly traded provider of premium jet charter experiences, has entered a definitive ...
The inducement grants were approved by ORIC’s Compensation Committee of the Board of Directors, as required by Nasdaq Rule 5635 (c) (4), and were granted as a material inducement to employment in ...
The Nifty index opened flat, and witnessed selling pressure in the first half, but saw a sharp recovery in the second half, ...
The SEC declares the Form S-4 effective, advancing the proposed business combination of Focus Impact BH3 Acquisition Co. and ...
Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib ...
Elliott Report on MSN8d
Airbnb canceled my booking, locked my account -- and kept my money!Can Airbnb cancel a booking at 4 a.m., lock your account and keep your money? That's what Nancy Kankindi wants to know after ...
Combination intended to create significant shareholder value in pursuit of a sustainable futureMESA, Ariz., Feb. 12, 2025 (GLOBE NEWSWIRE) ...
Ocala StarBanner on MSN14d
Dunnellon drama: Will the sheriff's office come in temporarily? Forever? Not at all?The city clerk told members they could post the police chief job listing in newspapers ... According to the document, under termination, there's a provision that states: "The agreement can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback